Cjc-With Dac
SKU: 387 | check_circle In Stock
CJC-1295 with DAC is a long-acting synthetic peptide developed to stimulate the body’s natural release of growth hormone by mimicking Growth Hormone–Releasing Hormone (GHRH). The inclusion of DAC (Drug Affinity Complex) allows the peptide to bind to serum albumin, significantly extending its activity in the bloodstream. This results in sustained elevation of growth hormone and IGF-1 levels over time. CJC-1295 with DAC is widely studied in research settings for its potential role in muscle development, recovery processes, fat metabolism, tissue repair, and healthy aging mechanisms. It is intended strictly for research purposes only and is not approved for human or veterinary use.
Product Overview
biotech Clinical Research Summary
Quick Specs
Related Products
Selank (10mg)
Selank is a synthetic regulatory peptide originally developed through neuropeptide research. It is best known for its study in anxiety regulation, stress response, and cognitive function. Selank is a heptapeptide (seven amino acids) and is a modified analogue of tuftsin, a naturally occurring peptide involved in immune and nervous system
Melanotan 1 (10mg)
Melanotan I (MT-1) is a synthetic peptide designed to mimic the effects of alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring hormone involved in skin pigmentation. It works by stimulating melanocortin-1 (MC1) receptors in melanocytes, which increases the production of melanin, the pigment responsible for skin color. In research and clinical contexts, Melanotan I has been studied for its ability to promote skin tanning without UV exposure and for its potential photoprotective effects, as increased melanin may help protect the skin from UV radiation. It has also been investigated in studies related to photosensitivity disorders. ⚠️ Important clarification: Melanotan I is not related to melanoma (skin cancer). Despite similar wording, Melanotan I is a pigmentation peptide, not a cancer-related compound.
Samaglutide (10mg)
Semaglutide is a synthetic peptide that acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the action of the natural GLP-1 hormone, helping regulate blood sugar levels and appetite. Semaglutide works by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting a feeling of fullness. Because of these effects, semaglutide is used in the management of type 2 diabetes and is widely studied for weight management and metabolic health. Its chemical structure allows for prolonged activity in the body, supporting sustained therapeutic effects.
CJC-1295 Whitout DAC 5mg+IPA 5 (10mg)
CJC-1295 demonstrates prolonged systemic distribution due to its modified peptide structure, which is designed to resist rapid enzymatic degradation. After administration, it circulates in the bloodstream and distributes to peripheral tissues, where it interacts with growth hormone–releasing hormone (GHRH) receptors, primarily in the pituitary region. The peptide’s extended half-life supports sustained exposure across tissues involved in metabolic regulation, protein synthesis, and cellular repair. Distribution characteristics may vary depending on formulation (with or without DAC), dose, and route of administration.
